Protein microarray analysis identifies key cytokines associated with malignant middle cerebral artery infarction

Area of Science:

• Biochemistry
• Immunology
• Neuroscience

Background:

• Malignant middle cerebral artery infarction (MMI) is a severe form of stroke with high mortality.
• Understanding the molecular mechanisms, particularly the role of cytokines, is crucial for developing effective treatments.

Purpose of the Study:

• To identify differentially expressed cytokines in patients with MMI.
• To elucidate the regulatory mechanisms and pathways involved in MMI pathogenesis.

Main Methods:

• Serum samples from MMI and non-acute cerebral infarction (NACI) patients were analyzed using a Human Cytokine Antibody Array.
• Statistical analyses (t-test, Fisher's Exact Test) identified differentially expressed cytokines.
• Gene Ontology, pathway enrichment, and protein-protein interaction network analyses were performed.

Main Results:

• Ten differentially expressed cytokines were identified, with four upregulated (NCAM1, IGFBP-6, LYVE1, LCN2) and six downregulated (TGFB1, EGF, PDGFA, MMP-10, IL-27, CCL2).
• The cytokine-cytokine receptor interaction pathway was significantly enriched.
• These cytokines showed altered expression levels in MMI compared to NACI.

Conclusions:

• The identified cytokines (NCAM1, LCN2, IGFBP-6, LYVE1, MMP-10, IL-27, PDGFA, EGF, CCL2, TGFB1) are potentially involved in MMI development.
• The cytokine-cytokine receptor interaction pathway may play a significant role in MMI.
• These cytokines represent potential diagnostic biomarkers and therapeutic targets for MMI.